EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

NLRP3 inflammasome: a key driver of neuroinflammation and a novel therapeutic target for neuropathic pain

Zana Montazeri-Khosh, Ahmad Ebrahimpour, Mahyar Hossein-Zargari, Parsa Taghizadeh-Tabrizi, Mohammad Safari-Sahlabadi, Mohammad Hosein Sheybani-Arani, Nahid Davoodian

Anesthesia and Pain Medicine · 31.10.2025 · 20 (4) · 341-356

DOI: 10.17085/apm.24132 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Anesthesia and Pain Medicine, erschienen am 31.10.2025. Verfasst von Zana Montazeri-Khosh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuropathic pain represents a serious complication arising from a spectrum of disorders that precipitate lesions within the central and peripheral nervous systems. This disabling pain can persist for years, severely diminishing the quality of life of the affected individuals. The treatment options available for neuropathic pain at present have limited efficacy. Moreover, the adverse effects associated with these options restrict their application. The exact etiological mechanisms underlying the pathogenesis of neuropathic pain remain unclear. However, neuroinflammatory processes mediated by the immune system play significant roles in the initiation and progression of neuropathic pain in various models. The nucleotide-binding domain and leucine-rich repeat pyrin-containing protein-3 (NLRP3) inflammasome, a pivotal element of the innate immune system, plays an indispensable role in the pathophysiological mechanisms of central and peripheral neuropathic pain. However, the precise mechanisms facilitating its activation in disparate neuropathic pain conditions remain to be elucidated. Gaining insights into the regulatory mechanisms affecting NLRP3 inflammasome activation in diverse neuropathic pain-associated disorders will aid in developing novel therapeutic avenues. Therefore, this review summarizes the current knowledge on the role of the NLRP3 inflammasome in the pathophysiology of several neuropathic pain-related conditions, such as diabetic neuropathic pain, chemotherapy-induced neuropathic pain, peripheral nerve compression, central nervous system neuropathic pain, radiculopathy, and morphine analgesic tolerance. In addition, this review also discusses the possible use of this inflammasome as a therapeutic target to alleviate the pain-related symptoms of these diseases.

Schlagwörter

Stichwörter der Autor:innen

Drug toleranceImmune systemInflammasomesInflammationNeuralgiaRadiculopathy

Autor:innen und Institutionen

  • Student Research Committee, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
  • Student Research Committee, Faculty of Pharmacy, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
  • Endocrinology and Metabolism Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
  • Department of Clinical Biochemistry, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

Zitieren

APA

Montazeri-Khosh, Z., Ebrahimpour, A., Hossein-Zargari, M., Taghizadeh-Tabrizi, P., Safari-Sahlabadi, M., Sheybani-Arani, M. H., & Davoodian, N. (2025). NLRP3 inflammasome: a key driver of neuroinflammation and a novel therapeutic target for neuropathic pain. Anesthesia and Pain Medicine, 20(4), 341-356. https://doi.org/10.17085/apm.24132

Vancouver

Montazeri-Khosh Z, Ebrahimpour A, Hossein-Zargari M, Taghizadeh-Tabrizi P, Safari-Sahlabadi M, Sheybani-Arani MH, et al. NLRP3 inflammasome: a key driver of neuroinflammation and a novel therapeutic target for neuropathic pain. Anesthesia and Pain Medicine. 2025;20(4):341-356. doi:10.17085/apm.24132

BibTeX
@article{MontazeriKhosh2025,
  author = {Montazeri-Khosh, Zana and Ebrahimpour, Ahmad and Hossein-Zargari, Mahyar and Taghizadeh-Tabrizi, Parsa and Safari-Sahlabadi, Mohammad and Sheybani-Arani, Mohammad Hosein and Davoodian, Nahid},
  title = {NLRP3 inflammasome: a key driver of neuroinflammation and a novel therapeutic target for neuropathic pain},
  journal = {Anesthesia and Pain Medicine},
  year = {2025},
  volume = {20},
  number = {4},
  pages = {341--356},
  doi = {10.17085/apm.24132}
}
Kostenlos starten →